insights_auto
Outlook: 34.8% bullish·0.0% bearish
Go to analysischevron_right
PFIZ34:BVMF
Pfizer BDR
R$35,15
0,00%
(0,00) 1D
9 ຕ.ລ., 17 ໂມງ 5 ນາທີ 00 ວິນາທີ GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PFIZ34...
Open
R$35,15
High
R$35,24
Low
R$34,65
Mkt. cap
161,19 ຕື້
Avg. vol.
8,98 ພັນ
Volume
16,59 ພັນ
52-wk high
R$37,70
52-wk low
R$30,09
Shares outstanding
5,70 ຕື້
No. of employees
75 ພັນ
Open
R$35,15
High
R$35,24
Low
R$34,65
Mkt. cap
161,19 ຕື້
Avg. vol.
8,98 ພັນ
Volume
16,59 ພັນ
52-wk high
R$37,70
52-wk low
R$30,09
Shares outstanding
5,70 ຕື້
No. of employees
75 ພັນ
News stories
From web sources and news partners
Simply Wall Street
·
21 ຊົ່ວໂມງກ່ອນ
Frontline Breast Cancer Approval Could Be A Big Moment For Pfizer Stock (PFE)
AD HOC NEWS
·
1 ມື້ກ່ອນ
Pfizer declares fourth-quarter dividend as Pfizer stock costs EUR 25.25
Yahoo Finance
·
2 ມື້ກ່ອນ
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
Profile
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America.
Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2025, 59% of the company's revenues came from the United States, 5% came from China, and 36% came from other countries.
The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000. Wikipedia
About Pfizer BDR
CEOAlbert Bourla
Employees75 ພັນ
Founded1849
Headquartersນິວຢອກ, ລັດນີວຢອກ, ສະຫະລັດ
SectorPharmaceutical industry
Websitepfizer.com